Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia

Experimental Neurology

Volumn 216, Issue 1, 2009, Pages 47-55

  Toyama, Kentaro ^a   Honmou, Osamu ^a,b,c,d   Harada, Kuniaki ^a   Suzuki, Junpei ^a   Houkin, Kiyohiro ^a   Hamada, Hirofumi ^a   Kocsis, Jeffery D ^c,d  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Angiogenesis; Regeneration; Stem and progenitor cells; Stroke; Transplantation

Indexed keywords

ANGIOPOIETIN 1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DNA MODIFICATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE; TREADMILL EXERCISE;

ANGIOPOIETIN-1; ANIMALS; BRAIN; CELLS, CULTURED; CEREBRAL ARTERIES; DISEASE MODELS, ANIMAL; GENE THERAPY; GENETIC VECTORS; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 59749103836     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2008.11.010     Document Type: Article

References (35)

1. Bates D.O., Hillman N.J., Williams B., Neal C.R., and Pocock T.M. Regulation of microvascular permeability by vascular endothelial growth factors. J. Anat. 200 (2002) 581-597
2. Baumgartner I., Pieczek A., Manor O., Blair R., Kearney M., Walsh K., and Isner J.M. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97 (1998) 1114-1123
3. Beck H., Acker T., Wiessner C., Allegrini P.R., and Plate K.H. Expression of angiopoietin-1, angiopoietin-2, and tie receptors after middle cerebral artery occlusion in the rat. Am. J. Pathol. 157 (2000) 1473-1483
4. Bederson J.B., Pitts L.H., Germano S.M., Nishimura M.C., Davis R.L., and Bartkowski H.M. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 17 (1986) 1304-1308
5. Carmeliet P., and Collen D. Molecular analysis of blood vessel formation and disease. Am. J. Physiol. 273 (1997) 2091-2104
6. Chen J., Li Y., Wang L., Lu M., Zhang X., and Chopp M. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J. Neurol. Sci. 189 (2001) 49-57
7. Chen J., Zhang Z.G., Li Y., Wang L., Xu Y.X., Gautam S.C., Lu M., Zhu Z., and Chopp M. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ. Res. 92 (2003) 692-699
8. Davis S., Aldrich T.H., Jones P.F., Acheson A., Compton D.L., Jain V., Ryan T.E., Bruno J., Radziejewski C., Maisonpierre P.C., and Yancopoulos G.D. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87 (1996) 1161-1169
9. Dvorak H.F., Brown L.F., Detmar M., and Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146 (1995) 1029-1039
10. Honma T., Honmou O., Iihoshi S., Harada K., Houkin K., Hamada H., and Kocsis J.D. Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Exp. Neurol. 199 (2006) 56-66
11. Horita Y., Honmou O., Harada K., Houkin K., Hamada H., and Kocsis J.D. Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J. Neurosci. Res. 84 (2006) 1495-1504
12. Iihoshi S., Honmou O., Houkin K., Hashi K., and Kocsis J.D. A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res. 1007 (2004) 1-9
13. Kastrup J. Therapeutic angiogenesis in ischemic heart disease: gene or recombinant vascular growth factor protein therapy?. Curr. Gene Ther. 3 (2003) 197-206
14. Kobune M., Kawano Y., Ito Y., Chiba H., Nakamura K., Tsuda H., Sasaki K., Dehari H., Uchida H., Honmou O., Takahashi S., Bizen A., Takimoto R., Matsunaga T., Kato J., Kato K., Houkin K., Niitsu Y., and Hamada H. Telomerized human multipotent mesenchymal cells can differentiate into hematopoietic and cobblestone area-supporting cells. Exp. Hematol. 31 (2003) 715-722
15. Krupinski J., Kaluza J., Kumar P., Kumar S., and Wang J.M. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 25 (1994) 1794-1798
16. Kurozumi K., Nakamura K., Tamiya T., Kawano Y., Kobune M., Hirai S., Uchida H., Sasaki K., Ito Y., Kato K., Honmou O., Houkin K., Date I., and Hamada H. BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol. Ther. 9 (2004) 189-197
17. Li Y., Chen J., Chen X.G., Wang L., Gautam S.C., Xu Y.X., Katakowski M., Zhang L.J., Lu M., Janakiraman N., and Chopp M. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 59 (2002) 514-523
18. Liu H., Honmou O., Harada K., Nakamura K., Houkin K., Hamada H., and Kocsis J.D. Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain 129 (2006) 2734-2745
19. Longa E.Z., Weinstein P.R., Carlson S., and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20 (1989) 84-91
20. Neumann-Haefelin T., Kastrup A., de Crespigny A., Yenari M.A., Ringer T., Sun G.H., and Moseley M.E. Serial MRI after transient focal cerebral ischemia in rats: dynamics of tissue injury, blood-brain barrier damage, and edema formation. Stroke 31 (2000) 1965-1972
21. Nomura T., Honmou O., Harada K., Houkin K., Hamada H., and Kocsis J.D. Intravenous infusion of BDNF gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience 136 (2005) 161-169
22. Onda T., Honmou O., Harada K., Houkin K., Hamada H., and Kocsis J.D. Therapeutic benefits by human mesenchymal stem cells (hMSC) and Ang-1 gene-modified hMSCs after cerebral ischemia. J. Cereb. Blood Flow Metab. 28 (2007) 329-340
23. Pettersson A., Nagy J.A., Brown L.F., Sundberg C., Morgan E., Jungles S., Carter R., Krieger J.E., Manseau E.J., Harvey V.S., Eckelhoefer I.A., Feng D., Dvorak A.M., Mulligan R.C., and Dvorak H.F. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab. Invest. 80 (2000) 99-115
24. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., Sato T.N., and Yancopoulos G.D. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87 (1996) 1171-1180
25. Suri C., McClain J., Thurston G., McDonald D.M., Zhou H., Oldmixon E.H., Sato T.N., and Yancopoulos G.D. Increased vascularization in mice overexpressing angiopoietin-1. Science 282 (1998) 468-471
26. Takahashi K., Ito Y., Morikawa M., Kobune M., Huang J., Tsukamoto M., Sasaki K., Nakamura K., Dehari H., Ikeda K., Uchida H., Hirai S., Abe T., and Hamada H. Adenoviral-delivered angiopoietin-1 reduces the infarction and attenuates the progression of cardiac dysfunction in the rat model of acute myocardial infarction. Mol. Ther. 8 (2003) 584-592
27. Thurston G., Suri C., Smith K., McClain J., Sato T.N., Yancopoulos G.D., and McDonald D.M. Leakage-resistant bloods in mice transgenically overexpressing angiopoietin-1. Science 286 (1999) 2511-2514
28. Ukai R., Honmou O., Harada K., Kiyohiro H., Hamada H., and Kocsis J.D. Mesenchymal stem cells derived from peripheral blood protects against ischemia. J. Neurotauma 24 (2007) 508-520
29. Wang W., Merrill M.J., and Borchardt R.T. Vascular endothelial growth factor affects permeability of brain microvessel endothelial cells in vitro. Am. J. Physiol. 271 (1996) C1973-C1980
30. Ward N.L., and Lamanna J.C. The neurovascular unit and its growth factors: coordinated response in the vascular and nervous systems. Neurol. Res. 26 (2004) 870-883
31. Yamauchi A., Ito Y., Morikawa M., Kobune M., Huang J., Sasaki K., Takahashi K., Nakmura K., Dehari H., Abe T., and Hamada H. Pre-administration of angiopoietin-1 followed by VEGF induces functional and mature vascular formation in a rabbit ischemic model. J. Gene. Med. 5 (2003) 994-1004
32. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., and Holash J. Vascular-specific growth factors and blood vessel formation. Nature 407 (2000) 242-248
33. Zhang Z., and Chopp M. Vascular endothelial growth factor and angiopoietins in focal cerebral ischemia. Trends. Cardiovasc. Med. 12 (2002) 62-66
34. Zhang Z.G., Zhang L., Jiang Q., Zhang R., Davies K., Powers C., Bruggen N., and Chopp M. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 106 (2000) 829-838
35. Zhang Z.G., Zhang L., Tsang W., Soltanian-Zadeh H., Morris D., Zhang R., Goussev A., Powers C., Yeich T., and Chopp M. Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 22 (2002) 379-392